Supporting I–O combination therapy development with correlative assays & biomarker discovery
Immuno-Oncology Insights 2023; 4(4), 161–169
Published: 15 May
Ana Rosa Saez Ibanez, Samik Upadhaya
Abi Pinchbeck, Assistant Editor, Immuno-Oncology Insights, speaks to (pictured left to right) Ana Rosa Saez-IbanezandSamik Upadhaya from the Cancer Research Institute, about their research in combination therapies across the I–O landscape and the importance of implementation of correlative assays in combination clinical trials.